Grant: Discovery Grants Program - Individual
Concordia University
$35,000.00
use of novel interstrand cross-linked DNA duplexes to investigate resistance to bifunctional alkylating chemotherapeutic agents
EF 2008-09
Résumé
Covalent DNA lesions play important roles in the treatment of cancer. Therapeutic alkylating agents, among some of the oldest anti-cancer agents, may be monofunctional or bifunctional; the latter category includes nitrogen mustards, chloroethyl-nitrosoureas and methyl methane sulfonates. These agents form interstrand cross-links, which if left unrepaired, prevent DNA strand separation and normal mitosis, interfere with transcription and induce apoptosis. A problem presented in cancer treatment is the development of resistance to the effects of these antitumor agents, often due to enhanced repair of the damage. Our group, through the synthesis and investigation of oligonucleotides that contain mimics of clinically relevant lesions formed during chemotherapy, hopes to advance our understanding of the mechanisms involved in their repair, an important step towards elucidating how some patients develop resistance to the effects of these chemotherapeutic agents.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
299384-2007
Name nom
Wilds, Christopher
Department département
Chemistry and Biochemistry
Organization id
70
Institution établissement
Concordia University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2007
Award amount
35000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
24
Committee name en
Inorganic & Organic Chemistry
Committee name fr
Chimie inorg. et org.
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3703
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic syntheses
Research subject fr
Synthèses organiques
Partie
2
Nb partie
3
Application title
use of novel interstrand cross-linked DNA duplexes to investigate resistance to bifunctional alkylating chemotherapeutic agents
Keyword
NA
Application summary
Covalent DNA lesions play important roles in the treatment of cancer. Therapeutic alkylating agents, among some of the oldest anti-cancer agents, may be monofunctional or bifunctional; the latter category includes nitrogen mustards, chloroethyl-nitrosoureas and methyl methane sulfonates. These agents form interstrand cross-links, which if left unrepaired, prevent DNA strand separation and normal mitosis, interfere with transcription and induce apoptosis. A problem presented in cancer treatment is the development of resistance to the effects of these antitumor agents, often due to enhanced repair of the damage. Our group, through the synthesis and investigation of oligonucleotides that contain mimics of clinically relevant lesions formed during chemotherapy, hopes to advance our understanding of the mechanisms involved in their repair, an important step towards elucidating how some patients develop resistance to the effects of these chemotherapeutic agents.